Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?

WHAT IS THIS SUMMARY ABOUT? This is a plain language summary of an article published in the journal Advances in Therapy. In 2020, the US Food and Drug Administration (also called the FDA) approved a medicine called vibegron to treat overactive bladder, also called OAB. The key results used to approv...

Descripción completa

Detalles Bibliográficos
Autores principales: Frankel, Jeffrey, Staskin, David, Varano, Susann, Newman, Diane K, Gregg, Steven G, Owens-Grillo, Janet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Becaris Publishing Ltd 2023
Materias:
Plain Language Summary of Publication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690438/
https://www.ncbi.nlm.nih.gov/pubmed/37586052
http://dx.doi.org/10.57264/cer-2023-0049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690438/
https://www.ncbi.nlm.nih.gov/pubmed/37586052
http://dx.doi.org/10.57264/cer-2023-0049

Ejemplares similares